Viemed Healthcare Revenue Growth & History (VMD)
Viemed Healthcare reported $270.3M in revenue for fiscal 2025, an increase of 20.52% from the previous fiscal year.
View full Viemed Healthcare company overviewViemed Healthcare annual revenue and growth
2018
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $270.3M | $46.0M | +20.52% |
| 2024 | 2024-12-31 | $224.3M | $41.2M | +22.54% |
| 2023 | 2023-12-31 | $183.0M | $44.2M | +31.82% |
| 2022 | 2022-12-31 | $138.8M | $21.8M | +18.60% |
| 2021 | 2021-12-31 | $117.1M | −$14.2M | −10.85% |
| 2020 | 2020-12-31 | $131.3M | $51.1M | +63.61% |
| 2019 | 2019-12-31 | $80.3M | $15.8M | +24.50% |
| 2018 | 2018-12-31 | $64.5M | — | — |
Viemed Healthcare quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $78.1M | $15.0M | +23.85% |
| Q1 2026 | 2026-03-31 | $75.4M | $16.3M | +27.54% |
| Q4 2025 | 2025-12-31 | $76.2M | $15.5M | +25.51% |
| Q3 2025 | 2025-09-30 | $71.9M | $13.9M | +23.98% |
| Q2 2025 | 2025-06-30 | $63.1M | $8.1M | +14.72% |
| Q1 2025 | 2025-03-31 | $59.1M | $8.5M | +16.87% |
| Q4 2024 | 2024-12-31 | $60.7M | $10.0M | +19.62% |
| Q3 2024 | 2024-09-30 | $58.0M | $8.6M | +17.41% |
| Q2 2024 | 2024-06-30 | $55.0M | $11.7M | +26.91% |
| Q1 2024 | 2024-03-31 | $50.6M | $11.0M | +27.90% |
| Q4 2023 | 2023-12-31 | $50.7M | $13.2M | +35.28% |
| Q3 2023 | 2023-09-30 | $49.4M | $13.6M | +38.15% |
| Q2 2023 | 2023-06-30 | $43.3M | $10.0M | +30.02% |
| Q1 2023 | 2023-03-31 | $39.6M | $7.3M | +22.64% |
| Q4 2022 | 2022-12-31 | $37.5M | $5.5M | +17.35% |
| Q3 2022 | 2022-09-30 | $35.8M | $6.5M | +22.11% |
| Q2 2022 | 2022-06-30 | $33.3M | $5.9M | +21.57% |
| Q1 2022 | 2022-03-31 | $32.3M | $3.8M | +13.51% |
| Q4 2021 | 2021-12-31 | $32.0M | $760,000 | +2.44% |
| Q3 2021 | 2021-09-30 | $29.3M | −$4.2M | −12.44% |
| Q2 2021 | 2021-06-30 | $27.4M | −$15.5M | −36.06% |
| Q1 2021 | 2021-03-31 | $28.4M | $4.6M | +19.36% |
| Q4 2020 | 2020-12-31 | $31.2M | $9.8M | +45.48% |
| Q3 2020 | 2020-09-30 | $33.4M | $13.1M | +64.21% |
| Q2 2020 | 2020-06-30 | $42.9M | $22.5M | +110.84% |
| Q1 2020 | 2020-03-31 | $23.8M | $5.7M | +31.42% |
| Q4 2019 | 2019-12-31 | $21.4M | $3.1M | +16.80% |
| Q3 2019 | 2019-09-30 | $20.4M | $3.4M | +20.31% |
| Q2 2019 | 2019-06-30 | $20.3M | $5.1M | +33.65% |
| Q1 2019 | 2019-03-31 | $18.1M | $4.2M | +29.74% |
| Q4 2018 | 2018-12-31 | $18.4M | — | — |
| Q3 2018 | 2018-09-30 | $16.9M | — | — |
| Q2 2018 | 2018-06-30 | $15.2M | — | — |
| Q1 2018 | 2018-03-31 | $14.0M | — | — |
Viemed Healthcare revenue growth trends
Over the last five reported fiscal years, revenue grew from $131.3M to $270.3M, a compound annual growth rate of 15.53%. Viemed Healthcare's latest reported quarter, Q2 2026, generated $78.1M in revenue, an increase of 23.85% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Viemed Healthcare source filings ↗